Inhaled Nitric Oxide Market 2025 to 2035
Inhaled Nitric Oxide Market 2025 to 2035
Inhaled Nitric Oxide Market (By Product Type: Gas, Delivery System; By Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2035.
Customisation Request
Revenue, 2025
USD 1.20 Bn
Forecast Year, 2035
USD 2.55 Bn
CAGR, 2025 - 2035
7.83%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global inhaled nitric oxide market, valued at USD 1.2 billion in 2025, is projected to reach USD 2.55 billion by 2035, growing at a CAGR of 7.83%, driven by rising respiratory disorders and advancements in pulmonary therapies.
Inhaled Nitric Oxide Market Size Analysis
Inhaled Nitric Oxide Market Size By Product Type 2025 to 2035 (USD Billion)
| Product Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gas | 0.47 | 0.51 | 0.55 | 0.59 | 0.64 | 0.69 | 0.74 | 0.80 | 0.86 | 0.93 | 1.01 |
| Delivery system | 0.73 | 0.78 | 0.85 | 0.91 | 0.98 | 1.06 | 1.14 | 1.23 | 1.33 | 1.43 | 1.54 |
Inhaled Nitric Oxide Market Size By Application 2025 to 2035 (USD Billion)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Neonatal Respiratory Treatment | 0.10 | 0.11 | 0.12 | 0.13 | 0.14 | 0.15 | 0.16 | 0.17 | 0.18 | 0.20 | 0.21 |
| Asthma and COPD | 0.26 | 0.29 | 0.31 | 0.33 | 0.36 | 0.39 | 0.42 | 0.45 | 0.48 | 0.52 | 0.56 |
| Acute Respiratory Distress Syndrome | 0.29 | 0.32 | 0.34 | 0.37 | 0.40 | 0.43 | 0.46 | 0.50 | 0.54 | 0.58 | 0.63 |
| Malaria Treatment | 0.54 | 0.58 | 0.63 | 0.68 | 0.73 | 0.79 | 0.85 | 0.92 | 0.99 | 1.07 | 1.15 |
Inhaled Nitric Oxide Market Size By Region 2025 to 2035 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.10 | 0.11 | 0.11 | 0.12 | 0.13 |
| Europe | 0.10 | 0.11 | 0.11 | 0.12 | 0.13 | 0.14 | 0.16 | 0.17 | 0.18 | 0.19 | 0.21 |
| Asia Pacific | 0.27 | 0.29 | 0.31 | 0.34 | 0.36 | 0.39 | 0.42 | 0.45 | 0.49 | 0.53 | 0.57 |
| Latin America | 0.32 | 0.35 | 0.38 | 0.41 | 0.44 | 0.47 | 0.51 | 0.55 | 0.59 | 0.64 | 0.69 |
| Middle East and Africa | 0.45 | 0.48 | 0.52 | 0.56 | 0.61 | 0.65 | 0.70 | 0.76 | 0.82 | 0.88 | 0.95 |
Inhaled Nitric Oxide Market Size to Lead USD 2.55 Billion by 2035
The global inhaled nitric oxide market size was estimated at USD 1.2 billion in 2025 and is projected to be worth around USD 2.55 billion by 2035 a CAGR of 7.83%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
